BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2204979)

  • 1. [Treatment of prolactinoma].
    Nadalon S; De Buhan B; Archambeaud-Mouveroux F; Fournier MP; Huc MC; Laubie B
    Rev Med Interne; 1990; 11(2):172-80. PubMed ID: 2204979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of prolactin-secreting pituitary adenomas.
    Molitch ME
    Pituitary; 2002; 5(2):55-65. PubMed ID: 12675502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolactin secreting pituitary adenomas: analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature.
    Ozgen T; Oruckaptan HH; Ozcan OE; Acikgoz B
    Acta Neurochir (Wien); 1999; 141(12):1287-94. PubMed ID: 10672299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of invasive giant prolactinomas.
    Yu C; Wu Z; Gong J
    Pituitary; 2005; 8(1):61-5. PubMed ID: 16411070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactinomas and resistance to dopamine agonists.
    Brue T; Pellegrini I; Priou A; Morange I; Jaquet P
    Horm Res; 1992; 38(1-2):84-9. PubMed ID: 1306523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
    Kobras G
    Pathologe; 1992 Jul; 13(4):183-9. PubMed ID: 1508856
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological changes in prolactinoma induced by bromocriptine treatment].
    Scanarini M
    Minerva Endocrinol; 1990; 15(1):13-5. PubMed ID: 2274009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice. Prolactinomas.
    Klibanski A
    N Engl J Med; 2010 Apr; 362(13):1219-26. PubMed ID: 20357284
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of a second temozolomide cycle in a patient with a prolactin-secreting pituitary carcinoma.
    Bilbao I; Egaña N; García C; Olaizola I
    Endocrinol Diabetes Nutr; 2017 Dec; 64(10):564-566. PubMed ID: 29137963
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of prolactinomas.
    Molitch ME; Thorner MO; Wilson C
    J Clin Endocrinol Metab; 1997 Apr; 82(4):996-1000. PubMed ID: 9100563
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
    Yokoyama M
    No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of the therapeutic results of bromocriptine treatment of prolactin microadenoma and macroadenoma].
    Jin ZM; Shi YF; Chen GL
    Zhonghua Nei Ke Za Zhi; 1990 Nov; 29(11):669-72, 702-3. PubMed ID: 2086009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical treatment of prolactinomas.
    Molitch ME
    Endocrinol Metab Clin North Am; 1999 Mar; 28(1):143-69, vii. PubMed ID: 10207689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.
    Hamilton DK; Vance ML; Boulos PT; Laws ER
    Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurosurgical management of prolactinomas.
    Gökalp HZ; Deda H; Attar A; Uğur HC; Arasil E; Egemen N
    J Neurosurg Sci; 2000 Sep; 44(3):128-32. PubMed ID: 11126446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine treatment of postoperative prolactinoma patients.
    Yang DY; Wang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):346-50. PubMed ID: 8087709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Economic Analysis of Bromocriptine Versus Trans-Sphenoidal Surgery for the Treatment of Prolactinoma.
    Duan L; Yan H; Huang M; Zhang Y; Gu F
    J Craniofac Surg; 2017 Jun; 28(4):1046-1051. PubMed ID: 28145933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.